Uncategorized

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.

A quickly evolving political landscape and challenges to reliable revenue streams led major for-profit providers to exercise restraint and reaffirm their 2025 outlooks.

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA scientists spend less time on repetitive tasks.

The Congressional Budget Office expects states will replace about half of the reduced federal support with their own resources, and then reduce spending by cutting provider payment rates, optional benefits and enrollment.

Stopping MA insurers from inflating their reimbursement is a better strategy to save federal dollars than restricting benefits or cutting eligibility in Medicaid, the Democrat lawmakers wrote to GOP leadership this week.

Insitro’s layoffs affect about 65 employees as the AI-focused biotech looks to advance its pipeline in metabolic disease and neuroscience.

The company plans to launch the lens, which supports vision at all distances, in Europe in the coming weeks.

Some providers may need to reduce services, lay off staff or close their doors if Congress enacts major cuts to the safety-net insurance program, experts say.

With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have railed against, the industry’s tumultuous ride is far from over.